$ABPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCENTIA BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACCENTIA BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in ACCENTIA BIOPHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 12 2013 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Sell | J | 0.01 | 1,375,000 | 13,750 | 1,960,992 | 3.3 M to 2 M (-41.22 %) | |
Feb 22 2013 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | Sell | J | 0.12 | 4,794,373 | 587,311 | 80,962,482 | 85.8 M to 81 M (-5.59 %) | |
Oct 26 2012 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | Sell | J | 0.00 | 500,000 | 0 | 3,335,992 | 3.8 M to 3.3 M (-13.03 %) |
Sep 14 2012 | ABPI | ACCENTIA BIOPHARMA ... | Hasara Garrison J. | Acting Chief Financ ... | Option Exercise | A | 0.15 | 109,654 | 16,448 | 109,654 | |
Sep 14 2012 | ABPI | ACCENTIA BIOPHARMA ... | Calder Douglas W | VP Strategic Plan/C ... | Option Exercise | A | 0.15 | 410,695 | 61,604 | 410,695 | |
Sep 14 2012 | ABPI | ACCENTIA BIOPHARMA ... | Santos Carlos | Sr. VP of Prod Dev/ ... | Option Exercise | A | 0.15 | 592,949 | 88,942 | 592,949 | |
Sep 14 2012 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | CEO/PRESIDENT/GENER ... | Option Exercise | A | 0.15 | 1,465,481 | 219,822 | 1,465,481 | |
Aug 31 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.39 | 124,494 | 48,827 | 85,756,855 | 85.9 M to 85.8 M (-0.14 %) |
Aug 31 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 85,881,349 | 86.3 M to 85.9 M (-0.46 %) |
Jun 04 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.42 | 104,133 | 43,476 | 86,281,349 | 86.4 M to 86.3 M (-0.12 %) |
Jun 04 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 86,385,482 | 86.8 M to 86.4 M (-0.46 %) |
May 01 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.51 | 79,929 | 40,676 | 86,785,482 | 86.9 M to 86.8 M (-0.09 %) |
May 01 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 86,865,411 | 87.3 M to 86.9 M (-0.46 %) |
Apr 13 2012 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | Sell | J | 0.37 | 100,000 | 37,000 | 3,835,992 | 3.9 M to 3.8 M (-2.54 %) |
Mar 09 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.58 | 57,242 | 33,200 | 87,265,411 | 87.3 M to 87.3 M (-0.07 %) |
Mar 09 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 87,322,653 | 87.7 M to 87.3 M (-0.46 %) |
Mar 09 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.34 | 88,499 | 30,090 | 87,722,653 | 87.8 M to 87.7 M (-0.10 %) |
Mar 09 2012 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 87,811,152 | 88.2 M to 87.8 M (-0.45 %) |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | Santos Carlos | Chief Science Offic ... | Option Exercise | A | 0.44 | 250,000 | 110,000 | 250,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | Calder Douglas W | VP Strategic Plan/C ... | Option Exercise | A | 0.44 | 250,000 | 110,000 | 250,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | Hasara Garrison J. | Acting Chief Financ ... | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | CEO/PRESIDENT/GENER ... | Option Exercise | A | 0.44 | 600,000 | 264,000 | 600,000 | |
Mar 02 2012 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | Option Exercise | A | 0.44 | 300,000 | 132,000 | 300,000 | |
Feb 17 2012 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | Sell | J | 0.00 | 125,000 | 0 | 3,935,992 | 4.1 M to 3.9 M (-3.08 %) |
Feb 17 2012 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | Sell | J | 0.00 | 375,000 | 0 | 0 | 375 K to 0 (-100.00 %) |
Dec 23 2011 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Executive Chairman | Sell | S | 0.20 | 500,000 | 100,000 | 4,060,992 | 4.6 M to 4.1 M (-10.96 %) |
Nov 30 2011 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.35 | 72,017 | 25,206 | 88,211,152 | 88.3 M to 88.2 M (-0.08 %) |
Nov 30 2011 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.75 | 400,000 | 300,000 | 88,283,169 | 88.7 M to 88.3 M (-0.45 %) |
Oct 06 2011 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Sell | J | 0.00 | 500,000 | 0 | 375,000 | 875 K to 375 K (-57.14 %) |
Apr 18 2011 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.00 | 290,499 | 0 | 88,683,169 | 89 M to 88.7 M (-0.33 %) |
Feb 24 2011 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.00 | 1,198,184 | 0 | 88,973,668 | 90.2 M to 89 M (-1.33 %) |
Feb 24 2011 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.71 | 869,686 | 617,477 | 90,171,852 | 91 M to 90.2 M (-0.96 %) |
Jan 12 2011 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Grant | A | 0.00 | 66,000 | 0 | 1,260,403 | 1.2 M to 1.3 M (+5.53 %) |
Dec 21 2010 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Buy | J | 0.00 | 206,896 | 0 | 1,194,403 | 987.5 K to 1.2 M (+20.95 %) |
Nov 29 2010 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Buy | P | 0.99 | 225,954 | 223,694 | 638,846 | 412.9 K to 638.8 K (+54.72 %) |
Nov 29 2010 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Grant | A | 0.00 | 750,000 | 0 | 750,000 | 0 to 750 K |
Nov 29 2010 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Grant | A | 0.00 | 750,000 | 0 | 987,507 | 237.5 K to 987.5 K (+315.78 %) |
Nov 26 2010 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | J | 0.00 | 17,925,720 | 0 | 91,041,538 | 73.1 M to 91 M (+24.52 %) |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 0.44 | 200,000 | 88,000 | 200,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 0.18 | 120,000 | 21,600 | 120,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.44 | 200,000 | 88,000 | 200,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.18 | 130,000 | 23,400 | 130,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 0.44 | 200,000 | 88,000 | 200,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 0.18 | 140,000 | 25,200 | 140,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 0.44 | 250,000 | 110,000 | 250,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 0.18 | 140,000 | 25,200 | 140,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Option Exercise | A | 0.44 | 2,500,000 | 1,100,000 | 2,500,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Option Exercise | A | 0.44 | 1,000,000 | 440,000 | 1,000,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | CHAIRMAN & CEO | Option Exercise | A | 0.18 | 60,000 | 10,800 | 60,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 0.44 | 2,500,000 | 1,100,000 | 2,500,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 0.18 | 1,000,000 | 180,000 | 1,000,000 | |
Aug 20 2010 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 0.18 | 50,000 | 9,000 | 50,000 | |
Aug 10 2010 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | PRESIDENT AND GENER ... | Option Exercise | A | 0.44 | 4,250,000 | 1,870,000 | 4,250,000 | |
Aug 10 2010 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | PRESIDENT AND GENER ... | Option Exercise | A | 0.18 | 2,000,000 | 360,000 | 2,000,000 | |
Aug 13 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.95 | 11,400 | 10,830 | 4,360,992 | 4.3 M to 4.4 M (+0.26 %) |
Aug 13 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.94 | 13,600 | 12,841 | 4,349,592 | 4.3 M to 4.3 M (+0.31 %) |
Aug 11 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.94 | 25,000 | 23,413 | 4,335,992 | 4.3 M to 4.3 M (+0.58 %) |
Aug 07 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.84 | 25,000 | 21,000 | 4,310,992 | 4.3 M to 4.3 M (+0.58 %) |
Aug 06 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.79 | 25,000 | 19,750 | 4,285,992 | 4.3 M to 4.3 M (+0.59 %) |
Aug 05 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.79 | 25,000 | 19,750 | 4,260,992 | 4.2 M to 4.3 M (+0.59 %) |
Aug 01 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.84 | 25,000 | 21,000 | 4,235,992 | 4.2 M to 4.2 M (+0.59 %) |
Aug 01 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 0.86 | 25,000 | 21,500 | 4,210,992 | 4.2 M to 4.2 M (+0.60 %) |
Apr 17 2008 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.81 | 27,500 | 22,275 | 27,500 | |
Apr 17 2008 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.81 | 27,500 | 22,275 | 27,500 | |
Apr 17 2008 | ABPI | ACCENTIA BIOPHARMA ... | CHAPMAN CHRISTOPHER C | Director | Option Exercise | A | 0.81 | 27,500 | 22,275 | 27,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | See General Remarks | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | See General Remarks | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | See General Remarks | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 2.61 | 20,000 | 52,200 | 20,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | A | 2.61 | 12,500 | 32,625 | 12,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | A | 2.61 | 12,500 | 32,625 | 12,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | A | 2.61 | 12,500 | 32,625 | 12,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 2.61 | 17,500 | 45,675 | 17,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 2.61 | 17,500 | 45,675 | 17,500 | |
Mar 04 2008 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 2.61 | 17,500 | 45,675 | 17,500 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.69 | 91,666 | 246,582 | 91,666 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.69 | 91,667 | 246,584 | 91,667 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 2.69 | 91,667 | 246,584 | 91,667 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 2.69 | 91,666 | 246,582 | 91,666 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 2.69 | 91,667 | 246,584 | 91,667 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 2.69 | 91,667 | 246,584 | 91,667 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | Chairman/CEO | Option Exercise | A | 2.69 | 33,333 | 89,666 | 33,333 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | Chairman/CEO | Option Exercise | A | 2.69 | 33,334 | 89,668 | 33,334 | |
Jan 09 2008 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | Chairman/CEO | Option Exercise | A | 2.69 | 33,334 | 89,668 | 33,334 | |
Dec 31 2007 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | A | 2.91 | 175,000 | 509,250 | 175,000 | |
Aug 14 2007 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | P | 8.87 | 875,000 | 7,761,250 | 875,000 | 0 to 875 K |
Jun 27 2007 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 3.06 | 6,667 | 20,401 | 20,000 | |
Jun 27 2007 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 3.06 | 6,667 | 20,401 | 20,000 | |
Jun 27 2007 | ABPI | ACCENTIA BIOPHARMA ... | Poole William | Director | Option Exercise | A | 3.06 | 6,666 | 20,398 | 20,000 | |
Jun 19 2007 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Option Exercise | A | 4.32 | 2,000,000 | 8,640,000 | 2,000,000 | |
Jun 19 2007 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Option Exercise | A | 4.32 | 200,000 | 864,000 | 200,000 | |
Jun 19 2007 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | A | 4.32 | 2,000,000 | 8,640,000 | 2,000,000 | |
Jun 19 2007 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Option Exercise | A | 4.32 | 2,000,000 | 8,640,000 | 2,000,000 | |
Jun 19 2007 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Option Exercise | A | 4.32 | 200,000 | 864,000 | 200,000 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 3.56 | 83,326 | 296,641 | 324,850 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 3.56 | 83,324 | 296,633 | 241,514 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 3.56 | 83,350 | 296,726 | 158,200 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | Pearce Alan M | Chief Financial Off ... | Option Exercise | A | 3.70 | 37,425 | 138,473 | 74,850 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 3.70 | 116,668 | 431,672 | 551,101 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 3.70 | 116,666 | 431,664 | 434,433 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 3.70 | 116,666 | 431,664 | 317,767 | |
Jan 26 2007 | ABPI | ACCENTIA BIOPHARMA ... | DUFFEY SAMUEL S | GENERAL COUNSEL | Option Exercise | A | 3.70 | 41,168 | 152,322 | 201,101 | |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Option Exercise | C | 0.50 | 8,021,861 | 4,010,931 | 0 | |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | J | 0.00 | 10,000,000 | 0 | 73,116,768 | 63.1 M to 73.1 M (+15.84 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | J | 0.00 | 5,000,000 | 0 | 63,116,768 | 58.1 M to 63.1 M (+8.60 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | J | 0.00 | 5,000,000 | 0 | 58,116,768 | 53.1 M to 58.1 M (+9.41 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Sell | J | 0.60 | 10,000,000 | 6,000,000 | 53,115,768 | 63.1 M to 53.1 M (-15.84 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | P | 0.01 | 17,902,062 | 179,021 | 63,115,768 | 45.2 M to 63.1 M (+39.59 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | P | 0.12 | 1,278,947 | 153,474 | 45,213,706 | 43.9 M to 45.2 M (+2.91 %) |
Nov 20 2006 | ABPI | ACCENTIA BIOPHARMA ... | ACCENTIA BIOPHARMACEUTICALS IN ... | 10% Owner | Buy | C | 0.50 | 16,043,722 | 8,021,861 | 43,934,759 | 27.9 M to 43.9 M (+57.52 %) |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 3.17 | 11,667 | 36,984 | 35,000 | |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 3.17 | 11,666 | 36,981 | 35,000 | |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | KING EDMUND | Director | Option Exercise | A | 3.17 | 11,666 | 36,981 | 35,000 | |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | THOMASON TODD D | Director | Option Exercise | A | 3.17 | 10,000 | 31,700 | 30,000 | |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | THOMASON TODD D | Director | Option Exercise | A | 3.17 | 10,000 | 31,700 | 30,000 | |
Nov 03 2006 | ABPI | ACCENTIA BIOPHARMA ... | THOMASON TODD D | Director | Option Exercise | A | 3.17 | 10,000 | 31,700 | 30,000 | |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | J | 8.00 | 4,333 | 34,664 | 4,385,992 | 4.4 M to 4.4 M (+0.10 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Buy | J | 8.00 | 5,339 | 42,712 | 3,634,160 | 3.6 M to 3.6 M (+0.15 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Buy | J | 8.00 | 5,339 | 42,712 | 3,634,160 | 3.6 M to 3.6 M (+0.15 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Buy | J | 8.00 | 252 | 2,016 | 34,414 | 34.2 K to 34.4 K (+0.74 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Buy | J | 8.00 | 4,333 | 34,664 | 4,385,992 | 4.4 M to 4.4 M (+0.10 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Buy | J | 8.00 | 2,084 | 16,672 | 434,243 | 432.2 K to 434.2 K (+0.48 %) |
Jun 23 2006 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Buy | J | 8.00 | 1,050 | 8,400 | 143,394 | 142.3 K to 143.4 K (+0.74 %) |
May 18 2006 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Buy | J | 0.00 | 412,892 | 0 | 412,892 | 0 to 412.9 K |
May 18 2006 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Buy | J | 0.00 | 412,892 | 0 | 412,892 | 0 to 412.9 K |
May 18 2006 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Buy | J | 0.00 | 412,892 | 0 | 412,892 | 0 to 412.9 K |
May 18 2006 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | J | 0.00 | 412,892 | 0 | 412,892 | 0 to 412.9 K |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Option Exercise | C | 0.00 | 320,205 | 0 | 0 | |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Option Exercise | C | 0.00 | 1,603,173 | 0 | 0 | |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Option Exercise | C | 0.00 | 612,602 | 0 | 0 | |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Grant | A | 8.00 | 200,000 | 1,600,000 | 4,381,659 | 4.2 M to 4.4 M (+4.78 %) |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Sell | C | 0.00 | 1,167,101 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOPKINS CAPITAL GROUP LLC | 10% Owner | Buy | C | 0.00 | 2,129,170 | 0 | 4,181,659 | 2.1 M to 4.2 M (+103.74 %) |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Option Exercise | C | 0.00 | 355,783 | 0 | 0 | |
Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Option Exercise | C | 0.00 | 1,781,304 | 0 | 0 |